QT
IGMS

Quantbot Technologies’s IGM Biosciences IGMS Stock Holding History

Quantbot Technologies’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-800
Closed -$7.72K – 1661
2024
Q1 		$7.72K Buy
+800
New +$9.27K ﹤0.01% 1468
2023
Q4 		– Sell
-1,800
Closed -$15K – 1772
2023
Q3 		$15K Buy
+1,800
New +$15.3K ﹤0.01% 1372
2022
Q4 		– Sell
-3,600
Closed -$81K – 1863
2022
Q3 		$81K Buy
+3,600
New +$72.7K 0.01% 1154
2022
Q2 		– Sell
-460
Closed -$12K – 1890
2022
Q1 		$12K Sell
460
-63
-12% -$1.17K ﹤0.01% 1439
2021
Q4 		$15K Buy
523
+423
+423% +$21K ﹤0.01% 1258
2021
Q3 		$6K Sell
100
-200
-67% -$15.3K ﹤0.01% 1396
2021
Q2 		$24K Buy
+300
New +$22.2K ﹤0.01% 1197
2021
Q1 		– Sell
-100
Closed -$8K – 1567
2020
Q4 		$8K Buy
+100
New +$7.03K ﹤0.01% 1122

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's IGMS Position: Q2 2024 in Review

Quantbot Technologies sold out of IGM Biosciences (IGMS) in Q2 2024, closing a stake of 800 shares — an estimated $7.72K sold.

Quantbot Technologies first reported a position in IGMS in Q4 2020 and held it in 8 quarters. The position peaked at $81K in Q3 2022. 82 funds tracked by Wall St. Rank hold IGMS as of Q2 2024.

  • Quantbot Technologies reported no remaining IGM Biosciences position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 800 IGM Biosciences shares in Q2 2024, an estimated $7.72K.
  • Quantbot Technologies first reported a position in IGM Biosciences in Q4 2020 and held it in 8 quarters.
  • Quantbot Technologies's IGM Biosciences position peaked at $81K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.